FDA 483 - Versiti Michigan Inc - October 30, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Versiti Michigan Inc. in Saginaw, MI, from October 26-30, 2019, revealed significant deviations from written standard operating procedures. Staff failed to consistently follow procedures during automated apheresis collection and donor screening, impacting alarm responses, documentation, needle adjustments, and donor vital sign measurements. These findings indicate a lack of adherence to established protocols for blood and blood component collection.
ID · 7c34bcca-be61-4dbb-a633-4170ef5346a9